ID: hyp-sda-2026-04-01-gap-9137255b-1
Hypothesis

Galectin-3 as Damage-Sensor Scaffold for Multimeric Cross-Seeding at Compromised Endo/Lysosomal Membranes

Galectin-3's carbohydrate recognition domain binds exposed glycans on ruptured endolysosomal membranes while its intrinsically disordered N-terminus provides a phase-separated condensation surface that recruits aggregation-prone proteins.
🧬 LGALS3🩺 neurodegeneration🎯 Composite 46%💱 $0.52▲5.2%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite

🧪 Overview

Galectin-3's carbohydrate recognition domain binds exposed glycans on ruptured endolysosomal membranes while its intrinsically disordered N-terminus provides a phase-separated condensation surface that recruits aggregation-prone proteins (Aβ42, α-synuclein, TDP-43) into localized high-concentration environments favoring cross-nucleation.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Endolysosomal Membrane Rupture<br/>Amyloid or Oxidative Stress"]
    B["Luminal Glycan Exposure<br/>beta-galactose on Damaged Membranes"]
    C["LGALS3 Galectin-3 CRD Domain<br/>Carbohydrate Recognition Domain Binds"]
    D["LGALS3 N-Terminal IDR<br/>Intrinsically Disordered Phase-Sep Region"]
    E["Phase-Separated Condensate<br/>Galectin-3 Scaffold at Rupture Site"]
    F["Aggregation-Prone Protein Concentration<br/>Cross-Seeding Opportunity"]
    G["Tau SNCA TDP43 FUS Recruitment<br/>Multi-Protein Cross-Seeding"]
    H["Multimeric Amyloid Propagation<br/>Endolysosomal Rupture Amplified"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports3 contradicts
Supports
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice.
Acta Neuropathol Commun2024PMID:39605053medium
Supports
ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation.
iScience2025PMID:40520109medium
Supports
Towards a TDP-43-Based Biomarker for ALS and FTLD.
Mol Neurobiol2018PMID:29460270medium
Supports
TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation.
bioRxiv2025PMID:40654715medium
Supports
Sephin1 reduces TDP-43 cytoplasmic mislocalization and improves motor neuron survival in ALS models.
Life Sci Alliance2025PMID:40602832medium
Contradicts
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Autophagy2021PMID:32048886medium
Contradicts
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders.
Int J Mol Sci2021PMID:33535376medium
Contradicts
Wallerian degeneration: the innate-immune response to traumatic nerve injury.
J Neuroinflammation2011PMID:21878125medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — LGALS3

No curated PDB or AlphaFold mapping for LGALS3 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for LGALS3 →

No DepMap CRISPR Chronos data found for LGALS3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0509
Events (7d)
0
Price History
▲5.2%

💾 Resource Usage

LLM Tokens
10,754
$0.0444
Total Cost
$0.0444
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
sourcev1_phase_c_backfill
origin_typedebate_synthesis
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.